Cargando…

General Practitioners' views on the provision of nicotine replacement therapy and bupropion

BACKGROUND: Nicotine replacement therapies (NRT) and a new drug, bupropion, are licensed in several countries as aids to smoking cessation. General practitioners (GPs) play a crucial role in recommending or prescribing these medications. In the UK there has been discussion about whether the medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: McEwen, Andy, West, Robert, Owen, Lesley
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59675/
https://www.ncbi.nlm.nih.gov/pubmed/11701091
http://dx.doi.org/10.1186/1471-2296-2-6
_version_ 1782120099669344256
author McEwen, Andy
West, Robert
Owen, Lesley
author_facet McEwen, Andy
West, Robert
Owen, Lesley
author_sort McEwen, Andy
collection PubMed
description BACKGROUND: Nicotine replacement therapies (NRT) and a new drug, bupropion, are licensed in several countries as aids to smoking cessation. General practitioners (GPs) play a crucial role in recommending or prescribing these medications. In the UK there has been discussion about whether the medications should be reimbursable by the National Health Service (NHS). This study assessed English GPs' attitudes towards reimbursement of NRT and bupropion. METHODS: Postal survey of a randomly selected national sample of GPs; 376 GPs completed the questionnaire after one reminder; effective response rate: 53%. There was no difference between the responses of GPs who responded to the initial request and those who responded only after a reminder suggesting minimal bias due to non-response. RESULTS: Attitudes of GPs were remarkably divided on most issues relating to the medications. Forty-three percent thought that bupropion should not be on NHS prescription while 42% thought that it should be (15% did not know); Fifty percent thought that NRT should not be on NHS prescription while 42% thought it should be (8% did not know). Requiring that smokers attend behavioural support programmes to be eligible to receive the medications on NHS prescription made no appreciable difference to the GPs' views. GPs were similarly divided on whether having the medications reimbursable would add unacceptably to their workload or offer a welcome opportunity to discuss smoking with their patients. A principal components analysis of responses to the individual questions on NRT and bupropion revealed that GPs' attitudes could be understood in terms of a single 'pro-con' dimension accounting for 53% of the total variance which made no distinction between the two medications. CONCLUSIONS: GPs in England appear to be divided in their attitudes to medications to aid smoking cessation and appear not to discriminate in their views between different types of medication or different aspects of their use. This suggests that their attitudes are generated by quite fundamental values. Addressing these values may be important in encouraging GPs to adhere more closely to national and international guidelines.
format Text
id pubmed-59675
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-596752001-11-09 General Practitioners' views on the provision of nicotine replacement therapy and bupropion McEwen, Andy West, Robert Owen, Lesley BMC Fam Pract Research Article BACKGROUND: Nicotine replacement therapies (NRT) and a new drug, bupropion, are licensed in several countries as aids to smoking cessation. General practitioners (GPs) play a crucial role in recommending or prescribing these medications. In the UK there has been discussion about whether the medications should be reimbursable by the National Health Service (NHS). This study assessed English GPs' attitudes towards reimbursement of NRT and bupropion. METHODS: Postal survey of a randomly selected national sample of GPs; 376 GPs completed the questionnaire after one reminder; effective response rate: 53%. There was no difference between the responses of GPs who responded to the initial request and those who responded only after a reminder suggesting minimal bias due to non-response. RESULTS: Attitudes of GPs were remarkably divided on most issues relating to the medications. Forty-three percent thought that bupropion should not be on NHS prescription while 42% thought that it should be (15% did not know); Fifty percent thought that NRT should not be on NHS prescription while 42% thought it should be (8% did not know). Requiring that smokers attend behavioural support programmes to be eligible to receive the medications on NHS prescription made no appreciable difference to the GPs' views. GPs were similarly divided on whether having the medications reimbursable would add unacceptably to their workload or offer a welcome opportunity to discuss smoking with their patients. A principal components analysis of responses to the individual questions on NRT and bupropion revealed that GPs' attitudes could be understood in terms of a single 'pro-con' dimension accounting for 53% of the total variance which made no distinction between the two medications. CONCLUSIONS: GPs in England appear to be divided in their attitudes to medications to aid smoking cessation and appear not to discriminate in their views between different types of medication or different aspects of their use. This suggests that their attitudes are generated by quite fundamental values. Addressing these values may be important in encouraging GPs to adhere more closely to national and international guidelines. BioMed Central 2001-10-30 /pmc/articles/PMC59675/ /pubmed/11701091 http://dx.doi.org/10.1186/1471-2296-2-6 Text en Copyright © 2001 McEwen et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
McEwen, Andy
West, Robert
Owen, Lesley
General Practitioners' views on the provision of nicotine replacement therapy and bupropion
title General Practitioners' views on the provision of nicotine replacement therapy and bupropion
title_full General Practitioners' views on the provision of nicotine replacement therapy and bupropion
title_fullStr General Practitioners' views on the provision of nicotine replacement therapy and bupropion
title_full_unstemmed General Practitioners' views on the provision of nicotine replacement therapy and bupropion
title_short General Practitioners' views on the provision of nicotine replacement therapy and bupropion
title_sort general practitioners' views on the provision of nicotine replacement therapy and bupropion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59675/
https://www.ncbi.nlm.nih.gov/pubmed/11701091
http://dx.doi.org/10.1186/1471-2296-2-6
work_keys_str_mv AT mcewenandy generalpractitionersviewsontheprovisionofnicotinereplacementtherapyandbupropion
AT westrobert generalpractitionersviewsontheprovisionofnicotinereplacementtherapyandbupropion
AT owenlesley generalpractitionersviewsontheprovisionofnicotinereplacementtherapyandbupropion